Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Pharmacy Practice|August 16, 2013
Antimicrobial stewardship and Clostridium difficile-associated diarrheaFrank J Piacenti, Kimberly D Leuthner
Pharmacotherapy|July 26, 2006
An update and review of antiretroviral therapyFrank J Piacenti
Journal of Clinical Microbiology|August 9, 2013
Antimicrobial stewardship programsKimberly D Leuthner, Gary V Doern
Antimicrobial Agents and Chemotherapy|January 27, 2006
Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniaeKimberly D Leuthner, Chrissy M Cheung, Michael J Rybak
The Journal of Antimicrobial Chemotherapy|June 22, 2006
Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureusKimberly D Leuthner, Chrissy M Cheung, Michael J Rybak
Expert Review of Anti-Infective Therapy|January 13, 2015
Dalbavancin (BI-387) for the treatment of complicated skin and skin structure infectionKimberly D Leuthner, Angela Yuen, Yu Mao, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolatesKimberly D Leuthner, Celine Vidaillac, Chrissy M Cheung, et al.
Clinical Therapeutics|December 5, 2002
Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infectionHoratio B Fung, Elizabeth A Stone, Frank J Piacenti
Antimicrobial Agents and Chemotherapy|March 30, 2006
Impact of Enterococcus faecalis on the bactericidal activities of arbekacin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus in a mixed-pathogen pharmacodynamic modelKerry L LaPlante, Michael J Rybak, Kimberly D Leuthner, et al.
Therapeutics and Clinical Risk Management|June 30, 2016
Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)Kimberly D Leuthner, Kristin A Buechler, David Kogan, et al.
Pageof 2